//
Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management
SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Trials
Heart failure with preserved ejection fraction: from mechanisms to therapies
Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Modifiable lifestyle factors and heart failure: A Mendelian randomization study
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction